Expertise in
1
conditions

Lai-ping J. Zhong

Department Of Oromaxillofacial Head And Neck Surgery, Center For Oromaxillofacial Head And Neck Disorders, 
Shanghai, CN 
Expertise in
1
conditions
Department Of Oromaxillofacial Head And Neck Surgery, Center For Oromaxillofacial Head And Neck Disorders, 
Shanghai, CN 

Overview

Lai-ping Zhong practices practicing medicine in Shanghai, China.

Zhong is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Oral Squamous Cell Carcinoma, Hemangiopericytoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Erdheim-Chester Disease.

They are actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 4 clinical trials.

Locations

Department Of Oromaxillofacial Head And Neck Surgery, Center For Oromaxillofacial Head And Neck Disorders, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients: A Single-arm Phase I Trial
Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients: A Single-arm Phase I Trial
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Toripalimab, Paclitaxel, Cisplatin
Study Phase: Phase 1
A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma
A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: November 22, 2023
Intervention Type: Radiation, Drug, Procedure
Study Drugs: Docetaxel, Cisplatin
Study Phase: Phase 2
Safety and Efficacy Evaluation of Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (Non NPC): A Phase I Trial
Safety and Efficacy Evaluation of Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (Non NPC): A Phase I Trial
Enrollment Status: Completed
Publish Date: April 05, 2023
Intervention Type: Drug
Study Drug: Carrimycin
Study Phase: Phase 1
Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: August 21, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

39 Total Publications

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study.
Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study.
Journal: EClinicalMedicine
Published: June 26, 2025

Frequently Asked Questions about Lai-ping J. Zhong

Is Lai-ping J. Zhong a top-rated expert for Oral Squamous Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Lai-ping J. Zhong is classified as an Elite expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lai-ping J. Zhong participate in research or clinical trials?

Yes. Lai-ping J. Zhong has published 39 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Lai-ping J. Zhong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhong's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile